201 filings
Page 7 of 11
8-K
zwsdkw4
9 May 19
UroGen Pharma Reports First Quarter 2019 Financial Results and Recent
8:12am
10-Q
72a0ty1lwahrep32b2wd
9 May 19
Quarterly report
7:13am
UPLOAD
1jfl54dv
8 May 19
Letter from SEC
12:00am
DEF 14A
at9s0 j37icy39kcaz4
26 Apr 19
Definitive proxy
5:00pm
10-K
bflwy 6f851yq
28 Feb 19
Annual report
1:08pm
8-K
ny0b 2qc7n9uvifhltm5
28 Feb 19
UroGen Pharma to Report Fourth Quarter and Full Year 2018 Financial Results
8:16am
424B5
onuuryg3bg
25 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
950 yuz5k
25 Jan 19
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
7:30am
424B5
dkm1uacifpddz5vh6jtq
22 Jan 19
Prospectus supplement for primary offering
5:12pm
8-K
64tqtonj
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm
8-K
xouqph6
9 Jan 19
UroGen Pharma Announces Positive Results ofUGN-101 from Pivotal
12:48pm
8-K
vjemkzz
4 Jan 19
Departure of Directors or Certain Officers
12:00am
6-K
nm587uawx9 i8yu7
13 Nov 18
Current report (foreign)
6:33am
6-K
a30zav
31 Oct 18
UGN-101 Joins Select Group of Urologic Oncology Product Candidates to Receive BTD
3:36pm
EFFECT
5jqm2bq50c yle7xkb
29 Oct 18
Notice of effectiveness
12:16am
CORRESP
gh1gr5 9m
24 Oct 18
Correspondence with SEC
12:00am
UPLOAD
wror42kbkppqb ec9h37
24 Oct 18
Letter from SEC
12:00am
S-8
9bvl16s3d55ipm3
12 Oct 18
Registration of securities for employees
5:27pm
F-3
t42e0t
12 Oct 18
Shelf registration (foreign)
5:24pm
6-K
xl5bq6rct2ua
1 Oct 18
Current report (foreign)
12:00am